Please wait

Exhibit 12.1

SALIX PHARMACEUTICALS, LTD.

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(in thousands)

 

     Quarter
Ended March 31,
     Year Ended December 31,  
     2014     2013      2013      2012      2011      2010     2009  

EARNINGS (LOSS)

                  

Net income (loss) before provision for income tax (1)

   $ (80,240   $ 33,959       $ 212,065       $ 111,828       $ 86,101       $ (24,203   $ (45,631

Fixed charges (1)

     43,078        15,628         62,891         56,667         32,879         21,141        7,275   
  

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Net Income (loss) before provision for income tax plus fixed charges

   $ (37,162   $ 49,587       $ 274,956       $ 168,495       $ 118,980       $ (3,062   $ (38,356
  

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

FIXED CHARGES

                  

Interest expense (1)

   $ 29,275      $ 5,131       $ 20,267       $ 19,766       $ 12,760       $ 8,857      $ 3,594   

Amortization of debt issuance costs and debt discount

     13,185        10,198         41,383         35,752         19,361         11,795        3,151   

Estimate of interest within rental expense

     618        299         1,241         1,149         758         489        530   
  

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Fixed Charges

   $ 43,078      $ 15,628       $ 62,891       $ 56,667       $ 32,879       $ 21,141      $ 7,275   
  

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

RATIO OF EARNINGS TO FIXED CHARGES

            3.17         4.37         2.97         3.62                  

COVERAGE DEFICIENCY (2)

   $ (80,240   $       $       $       $       $ (24,203   $ (45,631

 

(1) For the quarter ended March 31, 2014, income before taxes and fixed charges include $ 0.5 million of interest expense related to uncertain tax positions.
(2) Earnings were inadequate to cover fixed charges for the years ended December 31, 2010 and 2009 and the quarter ended March 31, 2014. As a result, a coverage deficiency is provided for those periods presented in which earnings were inadequate to cover fixed charges.